Which ETFs hold KVUE? Kenvue Inc is held by 2 funds tracked by ETFpeek.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 2 Oct 2026 | Carlton Lawson Group President of Europe, Middle East & Africa | BUY | Vested (RSU) | 36,597 | $629K | 40 |
| 2 Oct 2026 | Meredith Stevens Chief Operations Officer | BUY | Vested (RSU) | 35,754 | $615K | 40 |
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 2 Oct 2026 | Carlton Lawson Group President of Europe, Middle East & Africa | BUY | Vested (RSU) | 36,597 | $629K | 40 |
| 2 Oct 2026 | Meredith Stevens Chief Operations Officer | BUY | Vested (RSU) | 35,754 | $615K | 40 |
| 2 Oct 2026 | Matthew Orlando General Counsel | SELL | Vested (RSU) | 14,749 | $254K | 30 |
| 2 Oct 2026 | Matthew Orlando General Counsel | BUY | Vested (RSU) | 35,754 | $615K | 30 |
| 2 Oct 2026 | Meredith Stevens Chief Operations Officer | SELL | Vested (RSU) | 15,192 | $261K | 30 |
| 2 Oct 2026 | Caroline Tillett Chief Scientific Officer | SELL | Vested (RSU) | 8,471 | $146K | 30 |
| 2 Oct 2026 | Caroline Tillett Chief Scientific Officer | BUY | Vested (RSU) | 24,732 | $425K | 30 |
| 2 Oct 2026 | Heather Howlett Interim CFO & Chief Accounting Officer | SELL | Vested (RSU) | 5,566 | $96K | 30 |
| 2 Oct 2026 | Heather Howlett Interim CFO & Chief Accounting Officer | BUY | Vested (RSU) | 10,881 | $187K | 30 |
| 1 Oct 2026 | Michael Wondrasch Chief Technology & Data Officer | BUY | Option Exercise | 66,029 | — | 30 |
| 1 Oct 2026 | Michael Wondrasch Chief Technology & Data Officer | SELL | Vested (RSU) | 21,031 | $362K | 30 |
| 28 Sep 2026 | Richard E Jr Allison Director / Other | BUY | Vested (RSU) | 1,300 | — | 0 |
| 28 Sep 2026 | Jeffrey C Smith Director / Other | BUY | Vested (RSU) | 1,300 | — | 0 |
| 25 Sep 2026 | Meredith Stevens Chief Operations Officer | BUY | Option Exercise | 1,461 2 tranches | — | 30 |
| 25 Sep 2026 | Meredith Stevens Chief Operations Officer | SELL | Vested (RSU) | 1,461 2 tranches | $26K | 0 |
| Date | Fund | Direction | Shares Changed | % Δ ETF | % Δ Position |
|---|---|---|---|---|---|
| No trades recorded yet. | |||||
| No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal. | |||||